FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017103521> ?p ?o ?g. }

• W2017103521 endingPage "585" @default.
• W2017103521 startingPage "579" @default.
• W2017103521 abstract "Summary Context Acromegaly is characterized by GH excess and insulin resistance. It is not known which of these disorders is responsible for the increased atherogenic risk in these patients. Objective To analyse the associations of GH and homoeostasis model assessment ( HOMA ) with biomarkers of cardiovascular disease and to compare the above‐mentioned variables between patients with active acromegaly and controls. Design and setting This open cross‐sectional study was conducted at a U niversity H ospital. Patients Twenty‐two outpatients were compared with sex‐ and age‐matched control subjects. Main outcomes Included clinical features, hormonal status, markers of insulin resistance, lipoprotein profile and biomarkers of cardiovascular disease. Results Patients presented higher triglyceride (median [ IQR ]) (1·2[1·1–1·6] vs 0·9[0·6–1·1] m m , P < 0·05), low‐density lipoprotein‐cholesterol ( LDL ‐ C ) (mean ± SD ) (3·5 ± 0·9 vs 3·0 ± 0·7m m , P < 0·05), apoB (0·98 ± 0·23 vs 0·77 ± 0·22 g/l, P < 0·05), free fatty acid (0·69 ± 0·2 vs 0·54 ± 0·2 m M , P < 0·05), oxidized‐ LDL (120 ± 22 vs 85 ± 19 U /l, P < 0·05) and endothelin‐1 (0·90 ± 0·23 vs 0·72 ± 0·17 ng/l, P < 0·05) levels, increased cholesteryl ester transfer protein ( CETP ) activity (179 ± 27 vs 138 ± 30%/ml/h, P < 0·01) and lower C reactive protein ( CRP ) (0·25[0·1–0·9] vs 0·85[0·4–1·4] mg/l; P < 0·05) levels than control subjects. Vascular cell adhesion molecule ( VCAM ‐1) concentration was not different. By multiple linear regression analyses, HOMA explained the variability of triglycerides (25%), high‐density lipoprotein‐cholesterol ( HDL ‐ C ) (30%) and CETP activity (28%), while GH independently predicted LDL ‐ C (18%), oxidized‐ LDL (40%) and endothelin‐1 levels (19%). Conclusions In patients with active acromegaly, GH excess contributes to the development of insulin resistance, and the interaction between both disturbances would be responsible for the appearance of atherogenic pro‐oxidative and pro‐inflammatory factors. Insulin resistance would be preferably associated with an atherogenic lipoprotein profile and to high CETP activity, while high GH levels would independently predict the increase in LDL ‐ C , ox‐ LDL and endothelin‐1." @default.
• W2017103521 created "2016-06-24" @default.
• W2017103521 creator A5002356507 @default.
• W2017103521 creator A5010712499 @default.
• W2017103521 creator A5021002036 @default.
• W2017103521 creator A5027683875 @default.
• W2017103521 creator A5040057107 @default.
• W2017103521 creator A5074532146 @default.
• W2017103521 date "2012-09-11" @default.
• W2017103521 modified "2023-10-06" @default.
• W2017103521 title "GH levels and insulin sensitivity are differently associated with biomarkers of cardiovascular disease in active acromegaly" @default.
• W2017103521 cites W1860487341 @default.
• W2017103521 cites W1967357406 @default.
• W2017103521 cites W1968235589 @default.
• W2017103521 cites W1981532893 @default.
• W2017103521 cites W1982685226 @default.
• W2017103521 cites W1986731752 @default.
• W2017103521 cites W1992000752 @default.
• W2017103521 cites W1999364007 @default.
• W2017103521 cites W2000286377 @default.
• W2017103521 cites W2004881914 @default.
• W2017103521 cites W2007342896 @default.
• W2017103521 cites W2009977850 @default.
• W2017103521 cites W2014281571 @default.
• W2017103521 cites W2021523302 @default.
• W2017103521 cites W2034702553 @default.
• W2017103521 cites W2039290641 @default.
• W2017103521 cites W2050846761 @default.
• W2017103521 cites W2070318212 @default.
• W2017103521 cites W2082596521 @default.
• W2017103521 cites W2091880327 @default.
• W2017103521 cites W2094195895 @default.
• W2017103521 cites W2104259296 @default.
• W2017103521 cites W2112112197 @default.
• W2017103521 cites W2118341413 @default.
• W2017103521 cites W2118746168 @default.
• W2017103521 cites W2135012391 @default.
• W2017103521 cites W2137007782 @default.
• W2017103521 cites W2139390913 @default.
• W2017103521 cites W2140925625 @default.
• W2017103521 cites W2336144997 @default.
• W2017103521 cites W4237239340 @default.
• W2017103521 cites W4239068820 @default.
• W2017103521 cites W4244876089 @default.
• W2017103521 cites W4383301599 @default.
• W2017103521 doi "https://doi.org/10.1111/j.1365-2265.2012.04414.x" @default.
• W2017103521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22510144" @default.
• W2017103521 hasPublicationYear "2012" @default.
• W2017103521 type Work @default.
• W2017103521 sameAs 2017103521 @default.
• W2017103521 citedByCount "25" @default.
• W2017103521 countsByYear W20171035212013 @default.
• W2017103521 countsByYear W20171035212014 @default.
• W2017103521 countsByYear W20171035212015 @default.
• W2017103521 countsByYear W20171035212016 @default.
• W2017103521 countsByYear W20171035212018 @default.
• W2017103521 countsByYear W20171035212019 @default.
• W2017103521 countsByYear W20171035212020 @default.
• W2017103521 countsByYear W20171035212021 @default.
• W2017103521 countsByYear W20171035212022 @default.
• W2017103521 crossrefType "journal-article" @default.
• W2017103521 hasAuthorship W2017103521A5002356507 @default.
• W2017103521 hasAuthorship W2017103521A5010712499 @default.
• W2017103521 hasAuthorship W2017103521A5021002036 @default.
• W2017103521 hasAuthorship W2017103521A5027683875 @default.
• W2017103521 hasAuthorship W2017103521A5040057107 @default.
• W2017103521 hasAuthorship W2017103521A5074532146 @default.
• W2017103521 hasBestOaLocation W20171035212 @default.
• W2017103521 hasConcept C126322002 @default.
• W2017103521 hasConcept C134018914 @default.
• W2017103521 hasConcept C151730666 @default.
• W2017103521 hasConcept C2777391703 @default.
• W2017103521 hasConcept C2777433750 @default.
• W2017103521 hasConcept C2778163477 @default.
• W2017103521 hasConcept C2778913445 @default.
• W2017103521 hasConcept C2779306644 @default.
• W2017103521 hasConcept C2779343474 @default.
• W2017103521 hasConcept C2780072125 @default.
• W2017103521 hasConcept C2984496839 @default.
• W2017103521 hasConcept C62746215 @default.
• W2017103521 hasConcept C71315377 @default.
• W2017103521 hasConcept C71924100 @default.
• W2017103521 hasConcept C86803240 @default.
• W2017103521 hasConceptScore W2017103521C126322002 @default.
• W2017103521 hasConceptScore W2017103521C134018914 @default.
• W2017103521 hasConceptScore W2017103521C151730666 @default.
• W2017103521 hasConceptScore W2017103521C2777391703 @default.
• W2017103521 hasConceptScore W2017103521C2777433750 @default.
• W2017103521 hasConceptScore W2017103521C2778163477 @default.
• W2017103521 hasConceptScore W2017103521C2778913445 @default.
• W2017103521 hasConceptScore W2017103521C2779306644 @default.
• W2017103521 hasConceptScore W2017103521C2779343474 @default.
• W2017103521 hasConceptScore W2017103521C2780072125 @default.
• W2017103521 hasConceptScore W2017103521C2984496839 @default.
• W2017103521 hasConceptScore W2017103521C62746215 @default.
• W2017103521 hasConceptScore W2017103521C71315377 @default.
• W2017103521 hasConceptScore W2017103521C71924100 @default.
• W2017103521 hasConceptScore W2017103521C86803240 @default.

• next